Advanced BioDesign (@ABioDesign) header
Advanced BioDesign (@ABioDesign) profile picture

Overcoming Tumor Drug Resistance

Lyon, France
Joined March 2012
Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)Photo by Advanced BioDesign (@ABioDesign)
I am very happy to announce our participation in the #EHA2023 from June 8-11 in Frankfurt where we will be represented by Mileidys Perez (CSO). Through a poster entitled “ALDH1A AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA". EHA Library. Shaikh M. 06/08/2023; 386279; P450
1
110
Advanced BioDesign retweeted
📣 Happening today! Half-time retreat Day#4 with Mileidys Perez - @ABioDesign Aude Veinante Gardey - @LAVOIX_IP Joris van Arensbergen @JArensbergen - Annogen B.V. Koen Verhoef @NKI_nl and Carlo Chiavaroli - @VCLSsocial @MSCActions
6
12
Today is Triple-Negative Breast Cancer (#TNBC) Day. @ABioDesign, we are committed to fight against this aggressive cancer with its promising approach using #ALDHinhibitors. #cancer #tumorresistance
1
@ABioDesign receives the authorization from the French autohorities for its "First-In-Human" clinical trial "#ODYSSEY" https://teapawt.org/t.co/fVTlQUm18m
3
4
Initiate in 2020, our collaboration with the TIME team and Dr Bassam Janji is evolving into a new dimension with the “TRICK-ALDH” project. This collaboration will accelerate the launch of our innovative approach for the benefit of patients. lih.lu/blog/our-news-1/post/…
1
2
Advanced BioDesign retweeted
Interested in #enhancers and their role in human disease? Join the @EMBO workshop co-organized by @IglesiadRada @S_Spicuglia @susmandrup Registration 👉 https://teapawt.org/t.co/0rwbrByvnG Registr. deadline 👉27 August 2021 Abstract submission deadline 👉27 August 2021 #EMBOenhanceropathies
8
1
20
Here my first post for "All Eyes On Enhancers" #AEOE blog by @enhpathy_H2020 about my PhD project. @ABioDesign @MSCActions #enhanceropathies enhpathy.eu/sfa-post/uncover…
4
4
Today is #TNBCDay. At @ABioDesign we're working on the development of a new approach for resistant cancer like #tnbc with our program THERALDIN®TNBC. #oncology #tumorresistance https://teapawt.org/t.co/x7rK7nX48W
1
#JournéeInternationaleDuCancerDeLenfant « Se mobiliser pour faire reculer les cancers de l’enfant, de l’adolescent et du jeune adulte » est l’une des actions clés de la nouvelle #stratégieCancers, figurant dans la feuille de route 2021-2025. En savoir plus https://teapawt.org/t.co/VM07wnnd46
Despite breakthroughs treatments in #BreastCancer, the disease continues to affect millions of people. #TNBC (15% of #BreastCancer) have aggressive behaviour and lack of therapies. @ABioDesign is committed to create alternative for #TNBC. #pinktober https://teapawt.org/t.co/5Zq5O2o4DQ
@ABioDesign and Dr @bassam_janji and his team TIME (Tumor Immunotherapy and Microenvironment) from @LIH_Luxembourg will collaborate on tumour resistance. https://teapawt.org/t.co/c5njDhS30Z #oncology #precisionmedecine #tumorresistance
Platinum-based chemotherapy resistance is a major hurdle limiting treatment success in NSCLC. Recently, @ABioDesign publish in @oncogenejournal a real alternative to overcome this problem #targetedtherapy #precisionmedicine #lungcancer #oncology nature.com/articles/s41388-0…
Advanced BioDesign retweeted
Today's the last day to apply for the @enhpathy_H2020 PhD program from ITN @MSCActions. Ambitious international students who want to work on function and mechanisms of transcriptional enhancers in human diseases, apply here: enhpathy.eu
3
3
PhD Projects call are still open. Submit your application. Apply here https://teapawt.org/t.co/XMksGOi2l5 @MSCActions @enhpathy_H2020
10
10
Advanced BioDesign retweeted
OPEN CALL 15 PhD PROJECTS - Submit your application today! Apply here 👉 https://teapawt.org/t.co/vINdKsaXPn @MSCActions @Mariecurie_alum @YERUN_EU @Eurodoc
3
13
2
9